PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    7小时前 ms1000000847212667 来自新疆

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:单体;药理;胃肠疾病
    经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-03-25 ms2000000315947498 来自四川省

    1.02投稿,现在还在under review...一点消息无。等的心焦

    12

    展开12条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-05-08 ms8000001555903844 来自北京

    请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-03-01 ms2000002053337250 来自辽宁省

    想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-05-02 1225f99em69(暂无昵称) 来自北京

    状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-05-07 ms8000001555903844 来自北京

    大家submit to journal之后多久会变成with editor啊?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-05-07 ms8000001555903844 来自北京

    偏重的研究方向:药理学;心血管
    经验分享:请问submit to journal到with editor这一步大家都等了多久啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2023-12-28 samtol 来自浙江省

    让我修了两轮的格式和图片
    12.25 submitted to journal
    12.26 under editor assessment

    29

    展开29条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2022-08-10 msyukira

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:中药药理;中药复方
    经验分享:5.30投稿
    5.31要求提供缩略词,补充后当晚提交了
    6.6 under review
    6.22 Required Reviews Completed
    6.26 revise
    主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……
    7.14 summit
    7.15 Under Editor Assessment
    7.24 under review
    8.2 Required Reviews Completed
    8.3 Decision in Process
    8.4 accepted
    8.6 Proof

    感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:单体;药理;胃肠疾病<br>经验分享:怎么办呢,在编辑手里放了1个多月,现在变成Reviewer invited都十天了,怎么办啊,好想写催稿信,但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=7小时前, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编,之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬,最后投稿前生成的pdf里图片特别不清晰,但是下载下来又是清晰的,这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了,😭😭😭,正常吗难道五一也放假了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向:药理学;心血管<br>经验分享:请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]
    2024-04-15 ms6000000634273240 来自四川省

    请问proof返回后大概多久online啊,已经大半个月了还没有online🥹

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分